✦ LIBER ✦

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

✍ Scribed by Sandrine Faivre; Eric Raymond; Eveline Boucher; Jean Douillard; Ho Y Lim; Jun S Kim; Magaly Zappa; Silvana Lanzalone; Xun Lin; Samuel DePrimo; Charles Harmon; Ana Ruiz-Garcia; Maria J Lechuga; Ann Lii Cheng

Book ID: 117785062
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 178 KB
Volume: 10
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(09)70171-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II open-label study of sunitinib i

Phase II open-label study of sunitinib in patients with advanced breast cancer

✍ Denise A. Yardley, E. Claire Dees, Stephen D. Myers, Sherry Li, Paul Healey, Zhi 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 217 KB

A phase II open label trial evaluating s

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

✍ Tim F Greten; Alejandro Forner; Firouzeh Korangy; Gisele N'Kontchou; Nathalie Ba 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 790 KB

215 A PHASE II OPEN LABEL TRIAL EVALUATI

215 A PHASE II OPEN LABEL TRIAL EVALUATING SAFETY AND EFFICACY OF A TELOMERASE PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

✍ T.F. Greten; A. Forner; F. Korangy; G. N'Kontchou; N. Barget; C. Ayuso; L. Orman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Phase II, open-label study of brivanib a

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

✍ Jairo A. Garcia; Lewis R. Roberts 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 182 KB

An open-label, multicentre biomarker-ori

An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer

✍ M. Moehler; A. Mueller; J.T. Hartmann; M.P. Ebert; S.E. Al-Batran; P. Reimer; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 744 KB

3535 POSTER Phase II trial investigating

3535 POSTER Phase II trial investigating the efficacy and safety of sunitinib in patients with unresectable hepatocellular carcinoma (HCC)

✍ S.J. Faivre; E. Raymond; J. Douillard; E. Boucher; H.Y. Lim; J.S. Kim; S. Lanzal 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB